Comparison of remission and EULAR good response rates in 1677 patients with rheumatoid arthritis receiving methotrexate, leflunomide or TNF-blocking agents:: Results from a longitudinal observational study

被引:0
|
作者
Kvien, TK
Schrumpf, M
Mowinckel, P
Mikkelsen, K
Nordvág, B
Kaufmann, C
Rodevand, E
机构
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Lillehammer Hosp Rheumat Dis, Dept Rheumatol, Lillehammer, France
[3] Univ Hosp No Norway, Dept Rheumatol, Tromso, Norway
[4] Buskerud Cent Hosp, Dept Rheumatol, Drammen, Norway
[5] St Olav Hosp, Dept Rheumatol, Trondheim, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:450 / 450
页数:1
相关论文
共 50 条
  • [41] Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease
    Mohammed, Reem Hamdy A.
    Farahat, Faisal
    Kewan, Hanady H.
    Bukhari, Mohammed A.
    SPRINGERPLUS, 2015, 4
  • [42] TNF Inhibitor Treatment in Rheumatoid Arthritis (RA) Patients with Moderate Versus High Disease Activity At Baseline: A Comparison of Utility Gains, Response and Remission Rates
    Lie, Elisabeth
    Lillegraven, Siri
    Fagerli, Karen M.
    Uhlig, Till
    Kvien, Tore K.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S220 - S220
  • [43] CROSS-SECTIONAL OBSERVATIONAL STUDY IN AUSTRALIAN REGIONAL PRIVATE PRACTICE: DESCRIPTION OF CHARACTERISTICS AND 2011A ACR/EULAR REMISSION RATES IN RHEUMATOID ARTHRITIS PATIENTS ON BIOLOGICAL DMARDS
    Kodali, R.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 33 - 33
  • [44] Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study
    D'Agostino, Maria-Antonietta
    Wakefield, Richard J.
    Berner-Hammer, Hilde
    Vittecoq, Olivier
    Filippou, Georgios
    Balint, Peter
    Moeller, Ingrid
    Iagnocco, Annamaria
    Naredo, Esperanza
    Ostergaard, Mikkel
    Boers, Maarten
    Gaillez, Corine
    Van Holder, Karina
    Le Bars, Manuela
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (10) : 1763 - 1769
  • [45] BIOMARKERS, RHEUMATOID ARTHRITIS AND TREATMENT RESPONSE TO ANTI-TNF ALFA AGENTS-RESULTS FROM A GROUP OF PATIENTS IN ROMANIA
    Gavrila, Bogdan Ion
    Ciofu, Claudia
    Ancuta, Ioan
    Stoica, Victor
    Bojinca, Mihai
    Ciotaru, Dan
    Surcel, Mihaela
    Munteanu, Adriana
    Urscaciuc, Cornel
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 14 - 14
  • [46] Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
    Haraoui, Boulos
    Sheriff, Maqbool
    Khraishi, Majed
    Starr, Michael
    Kelsall, John
    Baker, Milton
    Arendse, Regan
    Dixit, Sanjay
    Bensen, William
    Baer, Philip
    Faraawi, Rafat
    Rampakakis, Emmanouil
    Sampalis, John S.
    Otawa, Susan
    Lehman, Allen J.
    Nantel, Francois
    Shawi, May
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1090 - S1091
  • [47] Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
    Sherbini, Ahmad A.
    Gwinnutt, James M.
    Hyrich, Kimme L.
    Verstappen, Suzanne M. M.
    RHEUMATOLOGY, 2022, 61 (10) : 3930 - 3938
  • [48] Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
    Kaneko, Yuko
    Atsumi, Tatsuya
    Tanaka, Yoshiya
    Inoo, Masayuki
    Kobayashi-Haraoka, Hitomi
    Amano, Koichi
    Miyata, Masayuki
    Murakawa, Yohko
    Yasuoka, Hidekata
    Hirata, Shintaro
    Nagasawa, Hayato
    Tanaka, Eiichi
    Miyasaka, Nobuyuki
    Yamanaka, Hisashi
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (11) : 1917 - 1923
  • [49] The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis -: A six-month, longitudinal, observational, multicenter study
    Heiberg, MS
    Nordvåg, BY
    Mikkelsen, K
    Rodevand, E
    Kaufmann, C
    Mowinckel, P
    Kvien, TK
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2506 - 2512
  • [50] Adalimumab In Combination With High and Low Dose-Methotrexate In Rheumatoid Arthritis Patients With Inadequate Response To Methotrexate: Pharmacokinetic Results From The Musica Study
    Ahmed, Ghada
    Goss, Sandra L.
    Klein, Cheri E.
    Mozaffarian, Neelufar
    Kaeley, Gurjit S.
    Awni, Walid
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S623 - S624